Post-radioembolization yttrium-90 PET/CT-part 1: Diagnostic reporting

EJNMMI Research

Volumn 3, Issue 1, 2013, Pages 1-28

  Kao, Yung Hsiang ^a,b,c   Steinberg, Jeffrey D ^d   Tay, Young Soon ^a   Lim, Gabriel K Y ^a   Yan, Jianhua ^e   Townsend, David W ^e   Takano, Angela ^a   Burgmans, Mark C ^a   Irani, Farah G ^a   Teo, Terence K B ^a   Yeow, Tow Non ^a   Gogna, Apoorva ^a   Lo, Richard H G ^a   Tay, Kiang Hiong ^a   Tan, Bien Soo ^a   Chow, Pierce K H ^a,f,g   Satchithanantham, Somanesan ^a   Tan, Andrew E H ^a   Ng, David C E ^a   Goh, Anthony S W ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c AUSTIN HOSPITAL   (Australia)

^d AGENCY FOR SCIENCE   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^g DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Bremsstrahlung SPECT CT; Diagnostic reporting; Non target activity; Selective internal radiation therapy; Yttrium 90 PET CT; Yttrium 90 radioembolization

Indexed keywords

LUTETIUM; MACROSALB TC 99M; MICROSPHERE; RESIN; UNCLASSIFIED DRUG; YTTRIUM 90; YTTRIUM 90 RESIN MICROSPHERE;

ADULT; AGED; ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; BREMS RADIATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INFERIOR VENA CAVA TUMOR THROMBOSIS; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MALE; NOISE; OPTICAL RESOLUTION; PANCREATIC NEUROENDOCRINE TUMOR; PORTAL VEIN TUMOR THROMBOSIS; POSITRON EMISSION TOMOGRAPHY; POSTRADIOEMBOLIZATION; PRIORITY JOURNAL; RADIODIAGNOSIS; RETROSPECTIVE STUDY; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR DIAGNOSIS; TUMOR THROMBUS; UNSPECIFIED SIDE EFFECT; VEIN EMBOLISM; VISCERAL METASTASIS;

EID: 84881223318     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-3-56     Document Type: Review

References (38)

1. Salem R, Thurston KG: Radioembolization with yttrium-90 microspheres: a state-ofthe-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. J Vasc Interv Radiol 2006, 17:1571-1593.
2. Sirtex Technology Pty Ltd, Lane Cove: Pilot study of Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres (SIR-Spheres microspheres) in patients with renal cell carcinoma (STX0110, "RESIRT"). New South Wales, Australia: Australiancancertrials.gov.au; 2010. Trial ID ACTRN12610000690055.
3. Muylle K, Nguyen J, de Wind A, Meuleman N, Delatte P, Vanderlinden B, Roelandts M, Van der Stappen A, Bron D, Flamen P: Radioembolization of the Spleen: A Revisited Approach for the Treatment of Malignant Lymphomatous Splenomegaly. Cardiovasc Intervent Radiol 2013, 36:1155-1160.
4. Hamoui N, Gates VL, Gonzalez J, Lewandowski RJ, Salem R: Radioembolization of renal cell carcinoma using yttrium-90 microspheres. J Vasc Interv Radiol 2013, 24:298-300.
5. Ricke J, Großer O, Amthauer H: Y90-Radioembolization of Lung Metastases via the Bronchial Artery: A Report of 2 Cases. Cardiovasc Intervent Radiol 2013. doi:10.1007/s00270-013-0690-3.
6. Riaz A, Lewandowski RJ, Kulik LM, Mulcahy MF, Sato KT, Ryu RK, Omary RA, Salem R: Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol 2009, 20:1121-1130.
7. Wang SC, Bester L, Burnes JP, Clouston JE, Hugh TJ, Little AF, Padbury RTA, Price D: Clinical care and technical recommendations for 90yttrium microsphere treatment of liver cancer. J Med Imaging Radiat Oncol 2010, 54:178-187.
8. Salem R, Lewandowski RJ, Gates VL, Nutting CW, Murthy R, Rose SC, Soulen MC, Geschwind JF, Kulik L, Kim YH, Spreafico C, Maccauro M, Bester L, Brown DB, Ryu RK, Sze DY, Rilling WS, Sato KT, Sangro B, Bilbao JI, Jakobs TF, Ezziddin S, Kulkarni S, Kulkarni A, Liu DM, Valenti D, Hilgard P, Antoch G, Muller SP, Alsuhaibani H, et al: Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol 2011, 22:265-278.
9. Sangro B, Iñarrairaegui M, Bilbao JI: Radioembolization for hepatocellular carcinoma. J Hepatol 2012, 56:464-473.
10. Lau WY, Kennedy AS, Kim YH, Lai HK, Lee RC, Leung TW, Liu CS, Salem R, Sangro B, Shuter B, Wang SC: Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Int J Radiat Oncol Biol Phys 2012, 82:401-407.
11. Kao YH, Hock Tan AE, Burgmans MC, Irani FG, Khoo LS, Gong Lo RH, Tay KH, Tan BS, Chow PKH, Eng Ng DC, Whatt Goh AS: Image-Guided personalized Predictive Dosimetry by Artery-Specific SPECT/CT Partition Modeling for Safe and Effective 90Y Radioembolization. J Nucl Med 2012, 53:559-566.
12. Kao YH, Tan EH, Teo TK, Ng CE, Goh SW: Imaging discordance between hepatic angiography versus Tc-99m-MAA SPECT/CT: a case series, technical discussion and clinical implications. Ann Nucl Med 2011, 25:669-676.
13. Kleinstreuer C, Basciano CA, Childress EM, Kennedy AS: A new catheter for tumor targeting with radioactive microspheres in representative hepatic artery systems. Part I: impact of catheter presence on local blood flow and microsphere delivery. J Biomech Eng 2012, 134:051004.
14. Jiang M, Fischman A, Nowakowski FS, Heiba S, Zhang Z, Knesaurek K, Weintraub J, Machac J: Segmental perfusion differences on paired Tc-99m macroaggregated albumin (MAA) hepatic perfusion imaging and yttrium-90 (Y-90) bremsstrahlung imaging studies in SIR-Sphere radioembolization: associations with angiography. J Nucl Med Radiat Ther 2012, 3:122.
15. Shen S, DeNardo GL, Yuan A, DeNardo DA, DeNardo SJ: Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung. J Nucl Med 1994, 35:1381-1389.
16. Rault E, Clementel E, Vandenberghe S, D'Asseler Y, Van Holen R, De Beenhouwer J, Staelens S: Comparison of yttrium-90 SPECT and PET images. J Nucl Med 2010, 51(suppl):125.
17. Elschot M, Nijsen JF, Dam AJ, de Jong HW: Quantitative evaluation of scintillation camera imaging characteristics of isotopes used in liver radioembolization. PLoS One 2011, 6:e26174.
18. Minarik D, Sjögreen Gleisner K, Ljungberg M: Evaluation of quantitative (90)Y SPECT based on experimental phantom studies. Phys Med Biol 2008, 53:5689-5703.
19. Fabbri C, Sarti G, Cremonesi M, Ferrari M, Di Dia A, Agostini M, Botta F, Paganelli G: Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry. Cancer Biother Radiopharm 2009, 24:145-154.
20. Ito S, Kurosawa H, Kasahara H, Teraoka S, Ariga E, Deji S, Hirota M, Saze T, Minamizawa T, Nishizawa K: (90)Y bremsstrahlung emission computed tomography using gamma cameras. Ann Nucl Med 2009, 23:257-267.
21. Selwyn RG, Nickles RJ, Thomadsen BR, DeWerd LA, Micka JA: A new internal pair production branching ratio of 90Y: the development of a non-destructive assay for 90Y and 90Sr. Appl Radiat Isot 2007, 65:318-327.
22. Lhommel R, van Elmbt L, Goffette P, Van den Eynde M, Jamar F, Pauwels S, Walrand S: Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIRSpheres. Eur J Nucl Med Mol Imaging 2010, 37:1654-1662.
23. Van Elmbt L, Vandenberghe S, Walrand S, Pauwels S, Jamar F: Comparison of yttrium-90 quantitative imaging by TOF and non-TOF PET in a phantom of liver selective internal radiotherapy. Phys Med Biol 2011, 56:6759-6777.
24. Walrand S, Flux GD, Konijnenberg MW, Valkema R, Krenning EP, Lhommel R, Pauwels S, Jamar F: Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging? Eur J Nucl Med Mol Imaging 2011, 38(suppl):S57-S68.
25. Bettinardi V, Presotto L, Rapisarda E, Picchio M, Gianolli L, Gilardi MC: Physical performance of the new hybrid PET/CT Discovery-690. Med Phys 2011, 38:5394-5411.
26. Bendriem B, Soussaline F, Campagnolo R, Verrey B, Wajnberg P, Syrota A: A technique for the correction of scattered radiation in a PET system using time-of-flight information. J Comput Assist Tomogr 1986, 10:287-295.
27. Werner ME, Surti S, Karp JS: Implementation and evaluation of a 3D PET single scatter simulation with TOF modeling. Proc. IEEE Nuclear Science Symp. Conf Rec 2006, 3:1768-1773.
28. Watson CC: Extension of single scatter simulation to scatter correction of time-offlight PET. IEEE Trans Nucl Sci 2007, 54:1679-1686.
29. Lhommel R, Goffette P, Van den Eynde M, Jamar F, Pauwels S, Bilbao JI, Walrand S: Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT. Eur J Nucl Med Mol Imaging 2009, 36:1696.
30. Kao YH, Tan EH, Ng CE, Goh SW: Yttrium-90 time-of-flight PET/CT is superior to Bremsstrahlung SPECT/CT for postradioembolization imaging of microsphere biodistribution. Clin Nucl Med 2011, 36:186-187.
31. Wissmeyer M, Heinzer S, Majno P, Buchegger F, Zaidi H, Garibotto V, Viallon M, Becker CD, Ratib O, Terraz S: 90Y Time-of-flight PET/MR on a hybrid scanner following liver radioembolisation (SIRT). Eur J Nucl Med Mol Imaging 2011, 38:1744-1745.
32. Carlier T, Eugène T, Bodet-Milin C, Garin E, Ansquer C, Rousseau C, Ferrer L, Barbet J, Schoenahl F, Kraeber-Bodéré F: Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT. EJNMMI Res 2013, 3:11.
33. Willowson K, Forwood N, Jakoby BW, Smith AM, Bailey DL: Quantitative (90)Y image reconstruction in PET. Med Phys 2012, 39:7153-7159.
34. Goedicke A, Berker Y, Verburg F, Behrendt F, Winz O, Mottaghy F: Study-parameter impact in quantitative 90-Yttrium PET imaging for Radioembolization Treatment Monitoring and Dosimetry. IEEE Trans Med Imaging 2013, 32:485-492.
35. Elschot M, Vermolen BJ, Lam MG, de Keizer B, van den Bosch MA, de Jong HW: Quantitative Comparison of PET and Bremsstrahlung SPECT for Imaging the In Vivo Yttrium-90 Microsphere Distribution after Liver Radioembolization. PLoS One 2013, 8:e55742.
36. Walrand S, Lhommel R, Goffette P, Van den Eynde M, Pauwels S, Jamar F: Hemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy. EJNMMI Res 2012, 2:20.
37. D'Arienzo M, Chiaramida P, Chiacchiararelli L, et al: 90Y PET-based dosimetry after selective internal radiotherapy treatments. Nucl Med Commun 2012, 33:633-640.
38. Kao YH, Steinberg JD, Tay YS, Lim GKY, Yan J, Townsend DW, Takano A, Burgmans MC, Irani FG, Teo TKB, Yeow TN, Gogna A, Lo RHG, Tay KH, Tan BS, Chow PKH, Satchithanantham S, Tan AEH, Ng DCE, Goh ASW: Post-radioembolization yttrium-90 PET/CT. Part 2: Dose-response and tumor predictive dosimetry for resin microspheres. EJNMMI Res. in press.